Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Operating Leases: 2022

Historic Operating Leases for Candel Therapeutics (CADL) over the last 1 years, with Dec 2022 value amounting to $1.5 million.

  • Candel Therapeutics' Operating Leases fell 31.16% to $1.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.1 million, marking a year-over-year decrease of 31.16%. This contributed to the annual value of $1.5 million for FY2022, which is N/A change from last year.
  • Latest data reveals that Candel Therapeutics reported Operating Leases of $1.5 million as of FY2022.
  • In the past 5 years, Candel Therapeutics' Operating Leases registered a high of $1.5 million during FY2022, and its lowest value of $1.5 million during FY2022.
  • Moreover, its 1-year median value for Operating Leases was $1.5 million (2022), whereas its average is $1.5 million.